Veozah Cost in 2026: Prices and How to Save
Veozah Cost in 2026: Prices and How to Save
If you've been prescribed Veozah for menopause hot flashes and then saw the price at the pharmacy counter, the sticker shock is real. A one-month supply of Veozah runs roughly $550 to $780 without insurance, and unlike many older drugs, there's no cheaper generic to fall back on. That's $6,600 to more than $9,000 a year for a single prescription.
The good part is that the full retail price isn't the only number that matters. What you actually pay depends on how you buy it, whether your plan covers it, and whether a different treatment might work just as well for far less.
At a glance
- Veozah (fezolinetant) costs about $550–$780 for a 30-day supply without insurance in the US as of 2026.
- There is no generic version, and patents could keep one off the market until 2031 or later.
- A December 2024 FDA boxed warning flags a rare risk of serious liver injury, so prescribers order regular liver blood tests.
- Cash-pay pricing through services like CanAmerica Plus (around $213 for a 30-day supply as of mid-2026) can come in well below standard retail.
- Generic non-hormonal alternatives like paroxetine, venlafaxine, and gabapentin can cost a fraction of Veozah and are worth discussing with your doctor.
How much does Veozah cost without insurance?
Veozah comes as one strength: a 45 mg tablet taken once a day. Because the dose doesn't change, your monthly cost is tied almost entirely to the price of 30 tablets.
Cash prices in 2026 generally land in this range:
| Supply | Typical cash price |
|---|---|
| 30 tablets (1 month) | $550–$780 |
| 90 tablets (3 months) | $1,650–$2,300 |
| 12 months | $6,600–$9,400 |
| 30 tablets via CanAmerica Plus | $212.99 |
The spread comes down to the pharmacy. The manufacturer's list price sits near $550 a month, but retail pharmacies add their own markup, which is why averages reported by pricing sites often climb toward $690–$780. Two pharmacies in the same zip code can quote prices that differ by more than $100 for the exact same bottle.
That variation is the single biggest reason to shop around. The first price you're quoted is rarely the lowest one available.
Why is Veozah so expensive?
Three things keep the price high.
It's brand-only. Veozah launched in 2023, and no generic competitor exists to pull the price down. When a drug has no generic, the manufacturer sets the price with little market pressure.
It's first-in-class. Fezolinetant, the active ingredient, was the first medication of its kind approved for hot flashes — a neurokinin 3 (NK3) receptor antagonist rather than a hormone. New mechanisms command premium pricing, especially early in a drug's life.
It's protected by patents. Veozah is shielded by multiple patents and a stretch of regulatory exclusivity. Key patents run into 2031 and 2034, which sets the floor for how long the brand can stay alone on the market.
Will there be a generic for Veozah?
Not soon. Based on current patent filings, the earliest a generic version of fezolinetant could realistically arrive is around 2031, and some protections extend to 2034. Timelines can shift if patents are challenged or licensing deals are struck, but planning around a generic in the next year or two isn't realistic.
For anyone trying to budget today, that matters: this is a brand-price medication for the foreseeable future, so the savings have to come from how you buy it or what you take instead — not from waiting for a generic.
What is Veozah, and how does it work?
Veozah treats moderate to severe vasomotor symptoms — the medical term for hot flashes and night sweats — caused by menopause. It's a non-hormonal option, which makes it relevant for women who can't or prefer not to take estrogen.
During menopause, falling estrogen disrupts a cluster of nerve cells in the brain that help regulate body temperature. Fezolinetant blocks the NK3 receptor those nerves use, which calms the misfiring that triggers a hot flash. Because it isn't a hormone, it works through a completely different pathway than traditional hormone therapy.
Most women don't feel the full effect immediately. In clinical trials, hot flash frequency and severity dropped within the first few weeks, with continued improvement over about 12 weeks. If you've taken it for a couple of months with no change, that's worth raising with your prescriber.
Veozah side effects and the liver warning
The most talked-about safety issue is the liver. In December 2024, the FDA added a boxed warning — its most serious type — after reports of rare but serious liver injury in people taking fezolinetant.
Because of that risk, the label calls for liver blood tests before you start, then monthly for the first three months, and again at six and nine months. Stop the medication and call your doctor right away if you notice yellowing of the skin or eyes, dark urine, nausea, unusual fatigue, or pain in the upper right abdomen — these can signal a liver problem.
More routine side effects tend to be milder: abdominal pain, diarrhea, trouble sleeping, back pain, and hot flashes that haven't fully settled yet. Weight gain isn't a recognized side effect of Veozah — that's a common mix-up with hormone therapy and certain antidepressants, but it hasn't shown up as a typical effect of fezolinetant.
Safety note: The liver monitoring schedule isn't optional. Skipping the blood tests to save a copay or a trip can mean missing an early warning sign. Factor the cost of lab work into your overall budget when you weigh Veozah against other options.
Does insurance cover Veozah?
Coverage is inconsistent. Some commercial plans cover Veozah with a prior authorization, meaning your doctor has to document that you tried or can't use other treatments first. Others place it on a high cost-sharing tier, and some don't cover it at all. Medicare Part D coverage varies plan to plan.
When a plan does cover it, your copay can still run high if Veozah sits on a specialty or non-preferred tier. And when a plan denies it, you're left paying full retail — which is exactly the situation where cash-pay pricing becomes worth a hard look.
The takeaway: don't assume insurance is automatically the cheaper route. For a non-covered or high-tier brand drug, the cash price can sometimes beat your own copay.
How to save on Veozah
A few practical moves can bring the cost down without compromising your care.
Compare cash prices across pharmacies. Because retail markups vary so much, the same prescription can swing more than $100 between stores. Check a few before you commit.
Look at cash-pay options. Services like CanAmerica Plus focus on transparent cash pricing for brand medications, which can land well below standard retail — the same approach that helps patients cut the cost of other pricey brand drugs like Eliquis. It's especially helpful when a drug isn't covered or sits on a high insurance tier. As of mid-2026, CanAmerica Plus lists Veozah at $212.99 for a 30-tablet supply, compared with $550 or more at typical US retail. Treat any cash price as one quote to compare against your pharmacy and your copay, not as the only answer.
Ask about a 90-day supply. Filling three months at once sometimes lowers the per-month price and cuts down on dispensing fees and pharmacy trips.
Talk to your doctor about alternatives. This is often the biggest lever. Several non-hormonal medications treat hot flashes for a small fraction of Veozah's price, and one might work well for you.
Savings tip: Before committing to a full month of any brand drug, ask your prescriber whether a generic alternative in the same treatment category is a reasonable first try. If it works, you could save thousands of dollars a year. If it doesn't, you've lost little.
Cheaper alternatives to Veozah for hot flashes
Veozah isn't the only non-hormonal way to treat hot flashes, and most alternatives cost dramatically less because they're available as generics. The trade-off is that the older options weren't designed specifically for menopause — they're medications found to help with hot flashes as a secondary use. Effectiveness and tolerability vary from person to person, so this is a conversation for you and your doctor.
| Treatment | Type | Approx. monthly cash cost | Notes |
|---|---|---|---|
| Veozah (fezolinetant) | Non-hormonal, NK3 blocker | $550–$780 | Brand-only; requires liver monitoring |
| Lynkuet (elinzanetant) | Non-hormonal, NK1/NK3 blocker | Brand pricing (new) | FDA approved Oct 2025; also targets sleep |
| Paroxetine (Brisdelle) | Low-dose SSRI | $10–$40 | Only SSRI FDA-approved for hot flashes |
| Venlafaxine (Effexor) | SNRI | $10–$40 | Commonly used off-label; well studied |
| Gabapentin | Nerve medication | $10–$30 | Often helps night sweats; can cause drowsiness |
| Estrogen therapy | Hormone | Varies; many generics | Most effective for VMS if not contraindicated |
A newer option is worth knowing about. Lynkuet (generic name elinzanetant) was approved by the FDA in October 2025. Like Veozah, it's non-hormonal and works on the NK3 receptor, but it also blocks the NK1 receptor, which is linked to sleep and mood. It's brand-only too, so it isn't a budget pick — but if hot flashes are wrecking your sleep, it's a development to ask your doctor about.
On the affordable end, generic paroxetine — sold in a low dose as Brisdelle specifically for hot flashes — is the only antidepressant FDA-approved for this use. Venlafaxine (brand name Effexor XR) and gabapentin are used off-label and have decades of real-world use behind them. For many women, one of these generics controls symptoms for $10 to $40 a month instead of several hundred — the same kind of savings that comes from choosing a generic antidepressant like sertraline over its brand-name version.
None of this means Veozah is the wrong choice. For some women, the older options don't work or cause side effects they can't tolerate, and a purpose-built drug is worth the price. The point is simply that you have choices, and the cheapest effective one is usually the right place to start.
The bottom line
Veozah is an effective, non-hormonal way to treat menopause hot flashes, but it carries a brand-only price tag of roughly $550–$780 a month with no generic on the horizon until at least 2031. Before you lock in that cost, compare cash prices across pharmacies and cash-pay services, check whether a 90-day fill lowers your per-month price, and ask your doctor whether a low-cost generic alternative is worth trying first. Pricing shifts often, so confirm the current number before you fill.
Frequently asked questions
Is Veozah an antidepressant?
No. Veozah (fezolinetant) is a non-hormonal NK3 receptor antagonist, not an antidepressant. Some antidepressants like paroxetine and venlafaxine are used to treat hot flashes, which is where the confusion comes from, but Veozah works through a different mechanism entirely.
Does Veozah cause weight gain?
Weight gain isn't a recognized side effect of Veozah in clinical trials. It's often confused with hormone therapy or certain antidepressants, which can affect weight. If you notice changes while taking it, mention them to your doctor, but fezolinetant itself isn't associated with weight gain.
How long does Veozah take to work?
Many women notice fewer and less intense hot flashes within the first few weeks, with continued improvement over roughly 12 weeks. If you've taken it consistently for two to three months without benefit, talk to your prescriber about whether it's the right fit.
Is there a generic for Veozah?
Not yet. No generic version of fezolinetant exists as of 2026, and patent protections could keep one off the US market until around 2031 or later. Savings for now come from cash-pay pricing or lower-cost alternatives, not from a generic.
Is Veozah cheaper than hormone therapy?
Usually not. Many forms of estrogen therapy are available as low-cost generics, while Veozah is a brand-only drug at several hundred dollars a month. Hormone therapy isn't safe for everyone, though, which is part of why non-hormonal options like Veozah exist. Your doctor can help weigh cost against your health history.
This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment. Pricing information is current as of the publication date but may change. Verify pricing directly before making purchasing decisions.